Friday, 11 October 2024 | 15:45 - 16:45
Session #4 : Cell and gene therapies
Format:In-personLocation:Petit Kursaal roomTrack:Conference
69 participants
Chairpersons : Pr John De Vos, INSERM U1183, CHU Montpellier and Dr Mathilde Girard, Urgo, Chenôve, FR
15:45 : Alloevasion approaches to IPSC-derived cell therapies
Dr Nikolaus Trede, Century Therapeutics, Philadelphia, USA
16:15 : Visioconference - Optimizing tumor reactivity and functions of therapeutic T cells
Dr Nathalie Labarriere, INCIT, UMR1302, Nantes, FRA
4 speakers
Head of Process Development